How Ph.D. was paid
$8.5M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Stock | Options | Incentive | Other | Total |
|---|---|---|---|---|---|---|
| Nello Mainolfi, Ph.D.Founder, President and Chief Executive Officer | $693,000 | — | $7,318,859 | $519,750 | $14,000 | $8,545,609 |
| Bruce Jacobs, CFA, MBAChief Financial Officer | $500,000 | $905,100 | $1,202,886 | $281,250 | $14,000 | $2,903,236 |
| Jared Gollob, M.D.Chief Medical Officer | $507,100 | $905,100 | $1,202,886 | $285,244 | $14,000 | $2,914,330 |
| Noah Goodman, MBAChief Business Officer | $293,992 | $1,052,500 | $1,631,056 | $181,726 | $12,794 | $3,172,068 |
| Brian Adams, J.D.Chief Legal Officer | $145,176 | $2,273,250 | $3,555,742 | $90,616 | $6,257 | $6,071,041 |
What changed and why
- $15.4MCEO total compensation decreased from $15,433,147 in 2024 to $8,545,609 in 2025.
- 3.4%Dr. Mainolfi received a base salary increase of 3.4% to $693,000.
- 60%Target bonuses for NEOs were set at 60% of salary for the CEO and 45% for other NEOs.
- New hire equity grants were awarded to Mr. Goodman and Mr. Adams during fiscal year 2025.
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.